Who owns BCYC?
Institutional ownership of Bicycle Therapeutics plc from Form 13F, Q2 2026
104 institutional managers reported holding Bicycle Therapeutics plc (BCYC) in Form 13F filings for Q2 2026, with 37,452,199 shares worth $159M. The largest reported holder was Baker Bros. Advisors LP. Managers that filed both quarters cut a net 7,465 shares (-0.0%). 19 opened new positions and 12 sold out.
- Funds holding
- 104
- Value held
- $159M
- New / sold out
- 19 / 12
- Net shares, same filers
- -0.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of BCYC
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Baker Bros. Advisors LP | $46.2M | 29.1% | 10,885,357 | Unchanged |
| FCPM III Services B.v. | $14.7M | 9.3% | 3,468,430 | Unchanged |
| Armistice Capital, LLC | $14.4M | 9.1% | 3,398,000 | Unchanged |
| Long Focus Capital Management, LLC | $14.0M | 8.8% | 3,310,687 | Unchanged |
| Acadian Asset Management LLC | $8.3M | 5.3% | 1,968,025 | Unchanged |
| Renaissance Technologies LLC | $6.5M | 4.1% | 1,533,400 | Added |
| GSK plc | $6.5M | 4.1% | 1,529,561 | Unchanged |
| Price T Rowe Associates Inc | $3.8M | 2.4% | 902,150 | Trimmed |
| Marshall Wace, LLP | $3.4M | 2.1% | 797,940 | Added |
| Qube Research & Technologies Ltd | $3.3M | 2.1% | 775,567 | Added |
| Morgan Stanley | $2.8M | 1.8% | 667,269 | Added |
| Schroder Investment Management Group | $2.6M | 1.6% | 615,833 | Unchanged |
| Citadel Advisors LLC | $2.3M | 1.5% | 554,225 | Added |
| Millennium Management LLC | $2.3M | 1.5% | 553,967 | Added |
| Peapod Lane Capital LLC | $2.3M | 1.4% | 537,978 | Added |
| Diadema Partners LP | $2.0M | 1.2% | 462,724 | Trimmed |
| Two Sigma Investments, LP | $1.8M | 1.2% | 434,577 | Added |
| Flax Pond Capital, LLC | $1.7M | 1.0% | 376,222 | Added |
| Jane Street Group, LLC | $1.7M | 1.0% | 392,163 | Added |
| Birchview Capital, LP | $1.3M | 0.8% | 313,616 | Trimmed |
| BlackRock, Inc. | $1.2M | 0.7% | 280,386 | Added |
| Moore Capital Management, LP | $1.2M | 0.7% | 275,000 | Unchanged |
| Rangeley Capital, LLC | $1.1M | 0.7% | 253,500 | Added |
| Palo Alto Investors LP | $856K | 0.5% | 201,890 | Unchanged |
| Sculptor Capital LP | $839K | 0.5% | 197,904 | New |
Share of 13F holdings is each fund's shares as a share of the 37,452,199 BCYC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Renaissance Technologies LLC Added+$2.3M
- Qube Research & Technologies Ltd Added+$2.0M
- Marshall Wace, LLP Added+$1.8M
- Peapod Lane Capital LLC Added+$1.8M
- Millennium Management LLC Added+$1.1M
- Two Sigma Investments, LP Added+$1.1M
- Flax Pond Capital, LLC Added+$890K
- Sculptor Capital LP New+$839K
- Citadel Advisors LLC Added+$751K
- Jane Street Group, LLC Added+$738K
Biggest sellers in Q2 2026
- Siren, L.L.C. Sold out-$7.2M
- Principal Financial Group Inc Sold out-$5.5M
- Silvercrest Asset Management Group LLC Sold out-$2.0M
- Platinum Investment Management LTD Sold out-$857K
- Birchview Capital, LP Trimmed-$636K
- Price T Rowe Associates Inc Trimmed-$535K
- Marex Group Ltd Sold out-$534K
- Man Group plc Sold out-$294K
- Engineers Gate Manager LP Sold out-$164K
- Axq Capital, LP Trimmed-$152K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $17.1M and sold $18.5M; 34 added and 17 trimmed.
Schedule 13D and 13G filings on BCYC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15Long Focus Capital Management, LLC SCHEDULE 13G filed by Bicycle Therapeutics plcSchedule 13G
- 2026-02-18ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Bicycle Therapeutics plcSchedule 13G
- 2025-05-15ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Bicycle Therapeutics plcSchedule 13G
- 2025-02-11WESTFIELD CAPITAL MANAGEMENT CO LP SCHEDULE 13G filed by Bicycle Therapeutics plcSchedule 13G
Questions about BCYC ownership
- Who owns BCYC stock?
- 104 institutional investment managers reported BCYC positions in their Form 13F filings for Q2 2026, holding 37,452,199 shares worth $159M in total. Baker Bros. Advisors LP reported the largest position.
- Are funds buying or selling BCYC?
- In Q2 2026, 19 managers opened new BCYC positions, 34 added, 17 trimmed and 12 sold out. Managers that filed in both quarters sold a net 7,465 shares.
- How current is this BCYC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BCYC by CUSIP. Options are left out. BCYC news and filings · BCYC insider trades · Top funds